SFRT alleviates symptoms associated with bulky advanced cancer: a retrospective single-center cohort analysis - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Spatially Fractionated Radiation Therapy on Symptom Management in Patients with Advanced Bulky Tumors: A Retrospective Cohort Study

  • By

  • Haiqin Zhang

  • Jian Zhang

  • Chen Su

  • Yanming Wang

  • Chuanyong Liu

  • Yan Dou

  • Jie Liu

  • Weichong Zhao

  • Sen Liu

  • Changsheng Cong

  • Jin Yu

  • Meili Sun

  • August 24, 2026

Share

--- --- ---

Clinical Scorecard: Impact of Spatially Fractionated Radiation Therapy on Symptom Management in Patients with Advanced Bulky Tumors: A Retrospective Cohort Study

At a Glance

Category

Detail

Condition

Advanced Bulky Tumors

Key Mechanisms

Spatially Fractionated Radiation Therapy (SFRT) delivers focused doses to tumor subregions, enhancing immune activation and preserving anti-tumor immune cells.

Target Population

Patients with bulky tumors defined as lesions ≥5 cm or metastatic lymph nodes ≥2 cm.

Care Setting

Oncology Department, Central Hospital affiliated with Shandong First Medical University

Key Highlights

  • 91.7% of patients experienced symptomatic improvement.

  • Overall response rate (ORR) was 33.3%, with a disease control rate (DCR) of 96.1%.

  • Median overall survival (OS) was 7.6 months.

  • Adverse events were mild to moderate, with no grade 3 or higher toxicities.

  • BED-Vertex ≥ 88 Gy was significantly associated with treatment response.

Guideline-Based Recommendations

Diagnosis

  • Bulky tumors defined as parenchymal lesions ≥5 cm or metastatic lymph nodes ≥2 cm.

Management

  • Utilize SFRT for patients with advanced bulky tumors lacking standard treatment options.

Monitoring & Follow-up

  • Assess treatment response through imaging and patient-reported outcomes.

Risks

  • Monitor for mild to moderate adverse events; no severe toxicities reported.

Patient & Prescribing Data

60 patients with advanced bulky tumors treated with SFRT.

SFRT shows potential in managing symptoms and tumor control with limited toxicity.

Clinical Best Practices

  • Individualize radiotherapy regimen based on tumor location and organ tolerance.

  • Consider BED-Vertex in treatment planning to enhance response rates.

Related Resources & Content

  • A Current Review of Spatial Fractionation: Back to the Future? — Authors: Cole Billena and Atif J. Khan; Publication: International Journal of Radiation Oncology, Biology, Physics; Date published: May 1, 2019 (online January 23, 2019).

  • Advances in Image-Guided Radiation Therapy — Authors: Laura A. Dawson and David A. Jaffray; Publication: Journal of Clinical Oncology; Date published: March 10, 2007.

  • Radiation Therapy to Treat Cancer — Author/organization: National Cancer Institute; Publication: National Cancer Institute website; Accessed August 25, 2026.

Original Source(s)

Related Content